Brief: Humanetics Selects Lifecore Biomedical To Deliver CDMO Services Supporting Development Of BIO 300 For The Prevention Of Acute Radiation Syndrome
17/03/2025 11:20
March 17 (Reuters) - Lifecore Biomedical Inc LFCR.O: HUMANETICS SELECTS LIFECORE BIOMEDICAL TO DELIVER CDMO SERVICES SUPPORTING DEVELOPMENT OF BIO 300 FOR THE PREVENTION OF ACUTE RADIATION SYNDROME Source text: ID:nGNX9Q1L3W Further company coverage: LFCR.O ((Reuters.Briefs@thomsonreuters.com))
Recent news on Lifecore Biomedical
See all newsNASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:40 AM
Lifecore Biomedical, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Lifecore Biomedical Reports Financial Results
Lifecore Biomedical Inc expected to post a loss of 22 cents a share - Earnings Preview